Leukemia Clinical Trials in San Antonio

Showing 1041-1056 of 1,056 trials

Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

NCT00485966

This is a Phase 2, open-label, multicenter, efficacy, safety, and pharmacodynamic study of CX-3543 in patients with relapsed or refractory B-cell chronic lymphocytic leukemia (CLL).

B-Cell Chronic Lymphocytic Leukemia

Cylene Pharmaceuticals25 participantsStarted Jun 2007

Scottsdale, Arizona, United States • Beverly Hills, California, United States • Albuquerque, New Mexico, United States +4 more locations

COMPLETEDPhase 3< 1 mile

Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery

NCT00683137

The study was done to evaluate the pain relief and safety of 2 valdecoxib doses compared to placebo in patients with moderate or severe pain following bunionectomy surgery, and to evaluate the effect of the 2 valdecoxib doses compared to placebo on health outcome measures and on the occurrence of opioid related symptoms.

PainHallux Valgus

Pfizer450 participantsStarted Oct 2002

Chandler, Arizona, United States • Glendale, Arizona, United States • Glendale, Arizona, United States +86 more locations

Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery

Leukemia Trials in Other Cities

Safety of ALK Ragweed Tablet

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Amonafide in Combination With Cytarabine in Secondary AML

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer

Other Conditions in San Antonio